全文获取类型
收费全文 | 13579篇 |
免费 | 740篇 |
国内免费 | 244篇 |
专业分类
耳鼻咽喉 | 54篇 |
儿科学 | 308篇 |
妇产科学 | 291篇 |
基础医学 | 1292篇 |
口腔科学 | 232篇 |
临床医学 | 1345篇 |
内科学 | 1000篇 |
皮肤病学 | 263篇 |
神经病学 | 76篇 |
特种医学 | 616篇 |
外科学 | 4293篇 |
综合类 | 2150篇 |
预防医学 | 427篇 |
眼科学 | 43篇 |
药学 | 908篇 |
2篇 | |
中国医学 | 525篇 |
肿瘤学 | 738篇 |
出版年
2024年 | 20篇 |
2023年 | 114篇 |
2022年 | 228篇 |
2021年 | 372篇 |
2020年 | 357篇 |
2019年 | 274篇 |
2018年 | 319篇 |
2017年 | 368篇 |
2016年 | 407篇 |
2015年 | 398篇 |
2014年 | 836篇 |
2013年 | 749篇 |
2012年 | 793篇 |
2011年 | 974篇 |
2010年 | 810篇 |
2009年 | 721篇 |
2008年 | 701篇 |
2007年 | 779篇 |
2006年 | 711篇 |
2005年 | 668篇 |
2004年 | 551篇 |
2003年 | 484篇 |
2002年 | 368篇 |
2001年 | 366篇 |
2000年 | 289篇 |
1999年 | 258篇 |
1998年 | 241篇 |
1997年 | 196篇 |
1996年 | 171篇 |
1995年 | 134篇 |
1994年 | 115篇 |
1993年 | 91篇 |
1992年 | 91篇 |
1991年 | 83篇 |
1990年 | 54篇 |
1989年 | 81篇 |
1988年 | 59篇 |
1987年 | 42篇 |
1986年 | 37篇 |
1985年 | 41篇 |
1984年 | 34篇 |
1983年 | 20篇 |
1982年 | 30篇 |
1981年 | 29篇 |
1980年 | 19篇 |
1979年 | 19篇 |
1978年 | 12篇 |
1977年 | 15篇 |
1976年 | 14篇 |
1973年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
《Journal of vascular and interventional radiology : JVIR》2022,33(4):359-367.e8
PurposeTo review and to compare indirectly the outcomes of minimally invasive therapies for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.Materials and MethodsA literature search via Medline and Cochrane Central databases was completed for randomized control studies published between January 2000 to April 2020 for the following therapies: Rezum, Urolift, Aquablation, and prostatic artery embolization (PAE). Data on the following variables were included: International prostate symptom score (IPSS), maximum urinary flow rate, quality of life, and postvoid residual (PVR). Standard mean differences between treatments were compared through a meta-analysis using transurethral resection of the prostate (TURP) to assess differences in treatment effect.ResultsThere was no significant difference in outcomes between therapies for IPSS at the 3, 6, and 12-month follow ups. Although outcomes for Rezum were only available out to 3 months, there were no consistently significant differences in outcomes when comparing Aquablation versus PAE versus Rezum. TURP PVR was significantly better than Urolift at 3, 6, and 12 months. No significant differences in minor or major adverse events were noted.ConclusionAlthough significant differences in outcomes were limited, Aquablation and PAE were the most durable at 12 months. PAE has been well studied on multiple randomized control trials with minimal adverse events while Aquablation has limited high quality data and has been associated with bleeding-related complications. 相似文献
2.
良性前列腺增生(BPH)是老年男性常见的泌尿系统疾病,其发病与前列腺慢性炎症之间存在显著相关。感染因子、尿液返流、代谢综合征、衰老过程和自身免疫应答在内的几种刺激,通过相应分子途径引起前列腺免疫细胞的组织定位和组成成分发生广泛改变,从而导致免疫系统失调,之后引发的组织损伤和缓慢愈合,导致了BPH发生和进展。本文通过总结良性前列腺增生与前列腺慢性炎症的相关性的临床研究结果,前列腺免疫细胞在病理生理机制层面与前两者之间的内在联系,以及抗炎药物对BPH-LUTS的干预作用,以其为BPH-LUTS的药物研发提供参考。 相似文献
3.
《Journal of the American College of Radiology》2020,17(10):1207-1219
PurposeLobular neoplasia (LN) detected on breast core needle biopsy is frequently managed with surgical excision because of concern for undersampled malignancy. The authors performed a systematic review and meta-analysis to estimate the risk for upgrade to malignancy in the setting of imaging-concordant classic LN diagnosed on core biopsy.MethodsPubMed and Embase were searched for original articles published from 1998 to 2020 that reported rates of upgrade to malignancy for classic LN, including atypical lobular hyperplasia (ALH) and classic lobular carcinoma in situ (LCIS). Two reviewers extracted study data and assessed the following quality criteria: exclusion of variant LCIS, exclusion of imaging-discordant lesions, and outcome reporting for ≥70% of lesions. For studies meeting all criteria, pooled risks for upgrade to any malignancy (invasive carcinoma or ductal carcinoma in situ) and invasive malignancy for all LN, ALH, and LCIS were estimated using random-effects models.ResultsFor 65 full-text articles included in the review, the risk for upgrade to any malignancy ranged from 0% to 45%. Among the 16 studies that met all quality criteria for the meta-analysis, pooled risks for upgrade to any malignancy were 3.1% (95% confidence interval [CI], 1.8%-5.2%) for all LN, 2.5% (95% CI, 1.6%-3.9%) for ALH, and 5.8% (95% CI, 2.9%-11.3%) for LCIS. Risks for upgrade to invasive malignancy were 1.3% (95% CI, 0.7%-2.4%) for all LN, 0.4% (95% CI, 0.0%-4.2%) for ALH, and 3.5% (95% CI, 2.0%-5.9%) for LCIS.ConclusionsThe risk for upgrade to malignancy for LN found on breast biopsy is low. Imaging surveillance can likely be offered as an alternative to surgical management for LN, particularly for ALH. 相似文献
4.
《Clínica e investigación en ginecología y obstetricia》2022,49(2):100721
Intravascular papillary endothelial hyperplasia or Masson's tumour is a non-neoplastic vascular lesion of reactive character. It is a rare diagnosis, clinically non-specific and with diverse locations. It is essential to take it into consideration and make a differential diagnosis with malignant vascular tumours such as angiosarcoma. Pathological study is fundamental for diagnosis. Treatment consists of complete resection of the tumour, including sufficiently wide margins to avoid recurrence.The case reported is an exceptional event, because of the pelvic location of the Masson's tumour that was diagnosed as part of the surgical staging of an ovarian cancer. 相似文献
5.
Kota Sahara Rin Yamada Takashi Fujiwara Koichi Koizumi Shin‐ichiro Horiguchi Tsunekazu Hishima Tatsuro Yamaguchi 《Digestive endoscopy》2015,27(7):768-771
Idiopathic myointimal hyperplasia of mesenteric veins (IMHMV) is a rare and poorly understood ischemic colitis that occurs in the rectosigmoid colon of predominantly young, previously healthy, male patients. A 76‐year‐old Japanese man presented to our hospital with a 1‐year history of worsening diarrhea, lower abdominal pain, and weight loss (−6 kg). Laboratory evaluation revealed white blood cell count of 13 200/μL, C‐reactive protein level of 2.0 mg/dL (normal range, 0.0–0.3), and negative results for stool culture (including Clostridium difficile). Colonoscopy showed circumferential and edematous narrowing of the sigmoid colon with deep longitude ulceration. Biopsy was done and examination of the specimen demonstrated no specific ischemia. The patient was treated with bowel rest, antibiotics, and i.v. fluids; however, his symptoms worsened. Finally, sigmoidectomy was carried out. Histological examination demonstrated significant myointimal hyperplasia of mesenteric veins leading to thickening and stenosis of the venous lumen. Therefore, the final diagnosis was IMHMV. Three months following sigmoidectomy, he was asymptomatic. 相似文献
6.
《Surgery (Oxford)》2022,40(11):731-737
Disorders of sex development (DSD) occur in 1–2/10,000 live births, with a specific molecular diagnosis only possible in 20% of cases. Presentation is usually at birth, and gender assignment must be avoided before review by an expert multidisciplinary team. Initial investigations allow a working diagnosis to be made within 48 hr. In 46,XY DSD, surgery may be necessary to correct hypospadias, reposition or remove undescended testes, and remove symptomatic Müllerian remnants. In 46,XX DSD, feminizing surgery is performed less frequently than in the past, but genitoplasty may still be indicated. Psychosocial support is required to promote positive adaptation as gender dissatisfaction can occur in certain conditions. Long-term outcome data are sparse. 相似文献
7.
目的 探讨前列腺癌非编码RNA1(PRNCR1)在前列腺癌早期诊断及预后的价值。方法 选取2012年1月至2015年10月在本院诊治前列腺癌患者45例、良性前列腺增生患者88例,进行PRNCR1检验。结果 PRNCR1 检验的灵敏度84.4%(38/45)、特异度90.9%(80/88)、阳性预测值82.6%(38/46)、阴性预测值92.0%(80/87)、符合率88.7%(118/133),PRNCR1在前列腺癌组织中含量高于癌旁组织和良性前列腺增生组织,差异有统计学意义(P<0.05)。两年内转移、复发、肿瘤死亡患者30例,其PRNCRA表达量高于两年内无转移、复发、死亡的患者(15例),差异有统计学意义(P<0.05)。结论 PRNCR1表达在诊断前列腺癌有价值,PRNCR1高表达与患者预后不良有关。 相似文献
8.
《Journal of vascular and interventional radiology : JVIR》2020,31(4):635-643
PurposeThis study evaluated the factors affecting contralateral and ipsilateral recurrent deep vein thrombosis (DVT) after iliac vein stent placement in patients with iliac vein compression syndrome (IVCS).Materials and MethodsData from 130 patients (95 female patients) who underwent catheter-directed thrombolysis and stent placement for IVCS with left lower leg thrombosis at a single institution were retrospectively analyzed. Mean patient age was 69.0 ± 14.0 years old. Median follow-up was 14 months (range, 3–164 months). Anticoagulation therapy was prescribed for 6 months, followed by lifelong antiplatelet therapy. Multivariate logistic regression analysis was performed to evaluate the factors affecting the development of contralateral and ipsilateral recurrent DVT.ResultsSeven patients (5.4%) developed contralateral DVT (median, 26 months; range, 2–61 months), and 11 patients (8.5%) developed ipsilateral DVT (median, 1 month; range, 0–53 months). Stent location (odds ratio [OR], 11.564; 95% confidence interval [CI], 1.159–115.417) and in-stent thrombosis during follow-up (OR, 15.142; 95% CI, 1.406–163.119) were predictors of recurrent contralateral DVT. Thrombophilia (OR, 47.560; 95% CI, 2.369–954.711), remaining inferior vena cava filter (OR, 30.552; 95% CI, 3.495–267.122), and in-stent thrombosis during follow-up (OR, 82.057; 95% CI, 2.915–2309.848) were predictors of ipsilateral DVT.ConclusionsContralateral DVT occurs late and is associated with extension of the iliac vein stent to the inferior vena cava and in-stent thrombosis. Ipsilateral DVT occurs relatively early and is associated with thrombophilia, remaining inferior vena cava filter, and in-stent thrombosis. 相似文献
9.
韩刚 高江平 洪宝发 王晓雄 文载律 唐杰 张旭 HAN Gang GAO Jiang-ping HONG Bao-fa WANG Xiao-xiong WEN Zai-lü TANG Jie ZHANG Xu 《中华泌尿外科杂志》2006,30(1):375-378
目的 探讨前列腺穿刺标本中磷酸化信号传导与转录激活因子3(P-STAT3)表达在前列腺癌(PCa)早期诊断中的应用价值.方法采用免疫组织化学方法检测接受重复穿刺的PCa患者初次穿刺未检出癌的标本(29例)、重复穿刺确诊PCa时的癌灶标本(29例)、重复穿刺确诊PCa时的非癌灶标本(29例)以及良性前列腺增生(BPH)患者初次穿刺标本(29例)中P-STAT3的表达.统计学分析其与临床诊断的相关性及对PCa发生的预测作用.结果 P-STAT3在PCa患者癌灶标本、非癌灶标本及初次穿刺标本中阳性表达率分别为93.1%(27/29)、82.8%(24/29)和86.2%(25/29),在BPH标本中阳性表达率为10.3%(3/29),前三者的阳性率明显高于后者(X2=60.123,P=0.000);如以初次穿刺标本中P-STAT3表达阳性作为PCa的诊断标准,该方法的敏感性为86.2%,特异性为89.7%.结论 检测穿刺标本P-STAT3表达可以作为前列腺穿刺活检的辅助诊断方法,用于PCa的早期诊断,预测PCa的发生. 相似文献
10.
中老年男性下尿路症状的流行病学调查 总被引:8,自引:3,他引:5
为了了解下尿路症状在中、老年男性中的流行情况,用附加了二个症状问题的SL问卷对871名52~74岁的男子作回顾性调查,对调查结果作了年龄分组分析。结果发现:平均IPSS总分为4.93分,无症状者为12.2%,轻症者为64.7%,中度症状者为19.6%,重症者为3.5%。夜尿者占72.3%,尿终滴沥占54.4%,而症状中分值>3分者尿终滴沥占25.6%,夜尿占14.6%,平均QOL为1.74,QOL为0~2、3、4~6的比例分别为52.7%、46.0%、1.3%。QOL与IPSS的相关性较好(r=0.62),与梗阻症状群的相关性(r=0.57)优于与刺激症状的相关性(r=0.44)。中重度症状者中有72.0%的人未进行治疗。 相似文献